KCR, a full-service contract research organization, is moving to a new office in Boston, MA, in the heart of the East Coast pharma/biopharma hub. The new KCR office, located at Rowes Wharf downtown, will support innovative R&D projects.  
 
“We are very excited about the new location in Boston and the ability to serve our U.S. clients on the same ground,” said Mike Jagielski, chief executive officer and president of KCR. “Boston is home to many life sciences companies, and we are proud to be part of this community.”
 
“KCR continues its growth strategy by expanding its capacities to provide clients with customized, reliable and high-quality clinical research services,” added Mr. Jagielski. “With our new Boston location, our U.S. presence as well as our strong East – West footprint across 20 countries in Europe, we are uniquely positioned to engage in the most challenging clinical research studies. This is another extraordinary achievement, given our 20th anniversary being celebrated in 2017.”